Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial

A. Drakaki, C.J. Kirby, M.S. Van Der Heijden, D.P. Petrylak, T. Powles, K.N. Chi, A. Fléchon, A. Necchi, L. Géczi, J.-L. Lee, G. Gakis, S. Bracarda, S. Chowdhury, C.-C. Lin, D. Keizman, U.N. Vaishampayan, A.H. Zimmermann, K. Bell-Mcguinn, D. Castellano

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)43-52
Number of pages10
JournalBladder Cancer
Volume6
Issue number1
DOIs
Publication statusPublished - 2020

Cite this